Our Products
Help Shape Patient Care Worldwide
As a leading innovation-driven organisation, Lilly is developing a growing portfolio of pharmaceutical products focused on meeting some of the world's most urgent medical needs in the fields of Cardiovascular, Diabetes, Men's health, Musculoskeletal, Neuroscience and Oncology.
New Zealand laws and regulations limit the amount of product information that we can provide to the general public via our website. We encourage patients wishing to obtain more detailed information on our products to speak to their healthcare professional.
The product information on this website is intended for New Zealand residents.
| Cardiovascular | Patients | Healthcare Providers | |
| Effient® (prasugrel) |  |
|
|
| Diabetes | Patients | Healthcare Providers | |
| Humalog® / Humalog® Mix25 / Humalog® Mix50 (insulin lispro) | |
|
|
| Humulin® (biosynthetic human insulin) and Humulin® Vials | |
|
|
| Men's Health | Patients | Healthcare Providers | |
| Cialis® (tadalafil) | |
|
|
| Musculoskeletal | Patients | Healthcare Providers | |
| Evista® (raloxifene hydrochloride) | |
|
|
| Forteo® (teriparatide of recombinant DNA origin) | |
|
|
| Neuroscience | Patients | Healthcare Providers | |
| Prozac® (fluoxetine hydrochloride) | |
|
|
| Strattera® (atomoxetine hydrochloride) | |
|
|
| Zyprexa® (olanzapine) - Tablets and Wafers | |
|
|
| Zyprexa® IM (olanzapine) - Injection | |
|
|
| Zyprexa® Relprevv (olanzapine) long acting injectable | |
|
|
| Oncology | Patients | Healthcare Providers | |
| Alimta® (pemetrexed) | |
|
